Skip to content

Bispectral Index and Surgical Field

Does Bispectral Index Improve Surgical Conditions During Fast Track Gynecological Benign Laparoscopies

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03911544
Enrollment
160
Registered
2019-04-11
Start date
2019-04-01
Completion date
2021-03-11
Last updated
2021-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Consciousness Monitors, Laparoscopy

Keywords

Neuromuscular Agents, Bispectral Index

Brief summary

This study investigates whether BIS monitor assisted anesthesia improves surgical space conditions during gynecological benign laparoscopic procedures. Half of participants will receive BIS monitor assisted anesthesia, while the other half will receive anesthesia without BIS monitor.

Detailed description

General Anesthesia includes hypnosis/unconsciousness, amnesia, analgesia, muscle relaxation and autonomic and sensory blockade of responses to noxious stimulation. Depth of anesthesia in standard practice is controlled by monitoring equipment such as blood pressure (BP), heart rate (HR), train of four ratio (TOF) and by clinical signs such as profuse sweating, tearing, cough and movements. BIS can be used as additional tool to monitor and manage anesthesia. BIS is an empirically derived scale for measuring brain electrical activity. It computes an index between 0 and 100, whereas 0 corresponds to no detectable brain electrical activity (flatline EEG) and 100 to awake state. A patient is considered to be appropriately anesthetized when the BIS' value is between 40 and 60.

Interventions

Participants allocated to the intervention group will receive TIVA anesthesia adjusted by the BIS monitoring in addition to clinical signs of poor anesthesia.

Sponsors

Aalborg University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women aged \> 18 years * American Society of Anesthesiology (ASA) physical status 1 or 2 * Legally competent

Exclusion criteria

* Age \< 18 years * ASA physical status ≥3 * Renal and/or lever disease * Relevant allergies towards anesthetics * Cancer surgery * No informed consent or inability to give that

Design outcomes

Primary

MeasureTime frameDescription
Proportion of optimal surgical field scoreup to 12 hoursscore 1 on a scale 1-4 (higher values represent a better outcome)

Secondary

MeasureTime frameDescription
Administration of neuromuscular blockup to 12 hoursTotal amount of neuromuscolar block given during anesthesia, expressed in milligrams
Amount of anesthetics, narcotic analgesics and other adjuvantsup to 12 hoursRegistration is in milligrams
BIS values (continues)up to 12 hourscontinues values
Event of PONV (postoperative nausea and vomiting) and antiemetic administration in post-anesthesia care unit (PACU)1 dayRegistration of the drugs in in milligrams
Amount of analgesics administered in PACU1 dayRegistration is in milligrams

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026